OUR TEAM

Viale, Alejandro

Group Director, Principal Researcher

viale@ibr-conicet.gov.ar

Alejandro M. Viale received a M.Sc. in Biochemistry (1977) at the Facultad de Bioquímica (FCByF), National University of Rosario, Argentina (UNR). He received a Fellowship from CONICET (1977-1981) to conduct studies in CEFOBI (supervisor: Dr. Rubén H. Vallejos) on the chemical modification of essential residues of the ATP synthetase of plants and bacteria. He obtained a Doctorate degree on this subject in 1981, and conducted post-doctoral studies in the laboratory of Dr. Takashi Akazawa, Research Institute for Biochemical Regulation, School of Agriculture, Nagoya University, Nagoya, Japón, on molecular biology of carbon fixation by photosynthetic bacteria. He was invited as Visiting Professor by Nagoya University (1987-1988) to continue these studies, and later returned to Argentina. In his country he obtained the positions of Professor of Microbiology at the FCByF (UNR), and Principal Investigator of CONICET working at the Instituto de Biología Molecular y Celular de Rosario (IBR) in which he is Head of the Antimicrobial Resistance Group. He retired from the Professorship position in 2021, but he retained his position in the IBR as Head of his Research Group. The current research activity of his group focuses in the resistance mechanisms to last-generation β-lactam antibiotics such as the carbapenems in aerobic Gram-negative bacteria of clinical relevance of the Acinetobacter and Pseudomonas genera, the genes involved, their evolution, dissemination, and environmental reservoirs.

https://www.scopus.com/authid/detail.uri?authorId=7006429498

contacto@conicet.gov.ar

Sede CCT Rosario

Ocampo y Esmeralda, Predio CONICET-Rosario
2000 Rosario, Santa Fe, Argentina
Tel. 54-341-4237070 / 4237500 / 4237200

Sede Facultad de Ciencias Bioquímicas y Farmacéuticas

Universidad Nacional de Rosario - Suipacha 531
2000 Rosario, Santa Fe, Argentina
Tel. +54 341 4350596 / 4350661 / 4351235

New paper release on @mbiojournal👉@garciavescovi and her team have discovered that Serratia marcescens uses UilS, a urea-induced enzyme, to adapt and thrive in urinary infections, even disrupting P. aeruginosa signals. Key insights for future treatments! #Microbiology #Research